M. Lebrin

Pre-Conditioning Methods and Novel Approaches with Mesenchymal Stem Cells Therapy in Cardiovascular Disease

A. Prats, M. Galinier, J. Roncalli, 2022, Cells.

Endoscopic ultrasound as a reliable tool for assessment of pancreatic adenocarcinoma treatment: Example of in situ gene therapy

L. Buscail, C. Canivet, O. Meyrignac, 2022, Endoscopy international open.

Adipose-Derived Stem Cells in the Treatment of Perianal Fistulas in Crohn’s Disease: Rationale, Clinical Results and Perspectives

L. Buscail, N. Vergnolle, C. Deraison, 2021, International journal of molecular sciences.

Direct evidence of sympathetic hyperactivity in patients with vasospastic angina.

F. Despas, D. Carrié, A. Pathak, 2017, American journal of cardiovascular disease.

Gene Therapy for Pancreatic Cancer: Specificity, Issues and Hopes

L. Buscail, P. Cordelier, B. Bournet, 2017, International journal of molecular sciences.

Pharmacology of levosimendan: inotropic, vasodilatory and cardioprotective effects

F. Despas, A. Pathak, J. Senard, 2013, Journal of clinical pharmacy and therapeutics.

Peripheral chemoreflex activation contributes to sympathetic baroreflex impairment in chronic heart failure

M. Esler, M. Labrunée, F. Despas, 2012, Journal of hypertension.

Intramyocardial transplantation of mesenchymal stromal cells for chronic myocardial ischemia and impaired left ventricular function: Results of the MESAMI 1 pilot trial.

J. Trochu, M. Galinier, J. Roncalli, 2016, International journal of cardiology.